Please scroll down to see this session’s presentations. At the session's scheduled start time, click on the presentation title to view each video.

Back to Basics

One-Hour Concurrent Session

Anticoagulation Controversies in the ICU

Monday, April 18, 2022

11:00 AM – 12:00 PM US CST

CE: 1.0

Concurrent Session Moderator(s)

Sarah Providence, BCCCP, BCPS, PharmD

Clinical Pharmacist
n/a

No relevant financial relationship(s) to disclose

Anticoagulation strategies and monitoring vary by institution. Laboratory monitoring protocols and applications in a variety of situations, including extracorporeal membrane oxygenation, will be reviewed. Quality assurance for this high-risk treatment with continuous evaluation of protocols and areas of practice improvement will be highlighted though clinical cases.

Learning Objectives:

Compare and contrast common monitoring modalities (anti-Xa or activated partial thromboplastin time [aPTT]) for unfractionated heparin, including advantages and disadvantages of each laboratory test
Describe anticoagulation monitoring strategies during extracorporeal life support: anti-Xa, aPTT, thromboelastography, activated clotting time
Discuss the use of bivalirudin-based anticoagulation, including advantages and disadvantages of a heparin-less strategy

Presentations:

Anti-Xa Monitoring for UFH: Benefits and Pitfalls
Concurrent Session Faculty: Ananth Anthes, PharmD, BCPS – n/a
Anticoagulation Controversies in Extracorporeal Life Support
Concurrent Session Faculty: Ryan Rivosecchi, BCCCP, PharmD – UPMC-Presbyterian Hospital
Case-Based Integration: Discordant aPTT Versus Anti-Xa Values
Concurrent Session Faculty: Deepali Dixit, BCCCP, BCPS, PharmD – Robert Wood Johnson University Hospital